AdventHealth Backs Local Arts in Ocala
AdventHealth is the presenting sponsor for Ocala's "Savor the Arts" fundraiser, an event aimed at bolstering local arts initiatives. The move reflects the health system's strategy of deep community engagement in its key Florida markets.
AdventHealth's community investments extend beyond single events, reflecting a broader strategy. In 2024, the health system awarded $1.4 million in Community Impact Grants to six Central Florida nonprofits to bolster workforce development in healthcare and other industries. This initiative aims to address the finding from a Community Health Needs Assessment that nearly half of the region's working residents struggle to pay their bills. The move toward community-based initiatives mirrors the healthcare industry's broader shift of services, like diagnostic imaging, out of traditional hospital settings. This trend is driven by major insurers restricting coverage for MRIs and CTs in hospital-based departments to direct patients toward lower-cost freestanding centers. Consequently, health systems are expanding their freestanding imaging footprints through acquisitions, joint ventures, and new construction. This site-of-care shift is particularly pronounced in states like Florida, which has seen a 25% increase in freestanding MRI and CT suites between 2023 and 2025 after repealing Certificate-of-Need laws. As a result, ambulatory surgical centers are projected to see the highest growth rate among end-users in the diagnostic imaging market, with a CAGR of 13.32% through 2031. AdventHealth operates over 30 imaging locations in Central Florida, including both hospital-based and freestanding facilities accredited by the American College of Radiology. This outpatient expansion is occurring alongside significant capital investment in traditional hospital infrastructure. AdventHealth Orlando is undertaking a $1 billion, multi-phase investment in its main campus, including a new 14-story medical tower slated to open in 2030. This project will add 440 inpatient beds, 24 operating rooms, and expanded imaging services. On the technology front, the FDA has approved hundreds of AI-enabled tools for medical imaging, with radiology accounting for 78% of new AI medical device approvals in early 2025. Vendors like GE Healthcare, Siemens Healthineers, and Philips lead the market in cleared AI algorithms. These tools assist with tasks such as flagging potential cancers, prioritizing urgent cases, and even drafting preliminary reports. Radiology practice management is adapting to these shifts, contending with staffing shortages and evolving reimbursement models. The 2026 Medicare Physician Fee Schedule is set to shift reimbursement away from hospital settings and toward office-based services. This change, along with a 2.5% "efficiency adjustment" cut to work RVUs for many non-E/M codes, will pressure imaging providers to optimize their service mix and billing practices. To navigate these challenges, some radiology groups are forming strategic partnerships or joining larger coalitions. These collaborations can provide greater leverage in payer negotiations, access to shared data for benchmarking, and potential savings on expenses like insurance premiums. This trend is part of a broader consolidation in the diagnostic imaging industry. The American College of Radiology (ACR) continues to guide clinical practice through its regularly updated Appropriateness Criteria. In late 2025, the ACR added 13 new and revised six existing topics, bringing the total to 270 diagnostic imaging and interventional radiology topics to help referring physicians choose the most suitable imaging exams.